Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bruker BioSpin is a global leader in the development and manufacturing of life science tools and analytical solutions, specifically focusing on magnetic resonance technologies. The company provides a comprehensive portfolio of Nuclear Magnetic Resonance (NMR), Electron Paramagnetic Resonance (EPR), and preclinical imaging systems, including MRI, PET, and micro-CT. These instruments are essential for structural biology, drug discovery, metabolomics, and materials science research. As a primary division of Bruker Corporation, BioSpin supports academic, pharmaceutical, and industrial researchers in understanding molecular structures and biological processes. Their innovations include ultra-high field magnets and cryogenically cooled probes that significantly enhance sensitivity and resolution in scientific analysis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bruker BioSpin.